Head-to-head · Cost-Efficiency Index
Framework vs HumeCare+
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Framework
Cost-first shoppers who want doctor-guided treatment selection with a named pharmacy, if you can accept learning the price only after intake.
Visit FrameworkHumeCare+
Cost-first shoppers who want not currently recommendable -- pricing is unverifiable and regulatory signals are internally inconsistent.
Visit HumeCare+The verdict
Framework takes it, leading the Cost-Efficiency Index 45 to 42. Framework is a personalized-plan GLP-1 telehealth platform offering compounded semaglutide and tirzepatide with doctor-guided treatment selection and a named pharmacy partner. HumeCare+ still earns a C — Cost-first shoppers who want not currently recommendable -- pricing is unverifiable and regulatory signals are internally inconsistent.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Framework.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Framework | HumeCare+ |
|---|---|---|
| Cost-Efficiency Index | 45/100 | 42/100 |
| Semaglutide / mo | Not disclosed | $199/mo (a floor, not the price: visible only after the medical intake; plus a separate fee at enrollment and every refill, never published; no dose stated, compounded) |
| Tirzepatide / mo | Not disclosed | $299/mo (visible only after the medical intake; plus a separate fee at enrollment and every refill, never published; no dose stated, compounded) |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #463 | #470 |
Framework
45/100Where the value is
- The compounding pharmacy partner is named, which most of this field does not do
- Treatment selection is doctor-guided rather than a fixed product menu
- US-licensed clinicians and a 503A pharmacy pathway
The tradeoffs
- No monthly medication price is published: the tirzepatide and semaglutide pages carry no price at all, and the homepage advertises a per-week figure for 'GLP-1s' generally rather than a rate for either drug
- The only drug-specific prices anywhere on the site sit on a legacy page — semaglutide at $349 per three months and tirzepatide at $549 per three months
HumeCare+
42/100Where the value is
- Genuinely prescribes semaglutide or tirzepatide via a named physician (Dr. Aaron Carter, MD, CMO)
- Includes muscle-preservation supplementation (glycine, B12, B6) as standard
- Proprietary 'Hume Pod' body-composition tracking device is a differentiated feature
The tradeoffs
- No actual price could be found anywhere on the live site -- the pricing template shows an unfilled '$[X]/mo' placeholder
- Regulatory badges shown are UK bodies (GPhC, CQC, MHRA) despite the site's own 'USA's No. 1' claim -- an unexplained inconsistency
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.